Arkolith/Insider Trading/PBYI/Form 4

Auerbach Alan H

President and CEO, Director, 10% OwnerPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jul 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$167K
Net Open-Market Flow
-$167K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2025Sell(S)22K$3.54$76K7.2M
Jul 8, 2025Sell(S)26K$3.53$90K7.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-022547) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML